Please Upload related files below
Fill in below.
Tell us the stocks you own using SnapTrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. SnapTrade only shares the tickers you own and your transaction history, not your account numbers. Using SnapTrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.
Don’t miss out on possible monetary recovery - link your account with SnapTrade.
On May 16, 2023 Doximity announced it was revising downwards its guidance for 2023. Management cited a major reason for this guidance reduction was softer-than-anticipated sales for upgrades to Doximity’s products. Consequently, analysts called into question the credibility of Doximity’s management because of management’s repeated guidance revisions over multiple quarters.
Following this news, DOCS’ stock price fell by $9.15 per share, or approximately 27% to close at $25.30 per share.